Bulk Manufacturer of Controlled Substances Application: Chattem Chemicals, 48512-48513 [2022-17011]
Download as PDF
<![CDATA[
48512
Federal Register / Vol. 87, No. 152 / Tuesday, August 9, 2022 / Notices
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment. All
requests for a hearing must be sent to:
(1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701
Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement
Administration, Attn: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing should
also be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on July 8, 2022, Curium
US LLC, 2703 Wagner Place, Maryland
Heights, Missouri 63043–3421, applied
to be registered as an importer of the
following basic class(es) of controlled
substance(s):
Controlled substance
Ecgonine ........................
Drug
code
9180
Schedule
II
The company plans to import small
quantities of a derivative form of the
listed controlled substance to be used in
diagnostic testing. No other activities for
this drug code is authorized for this
registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
Kristi O’Malley,
Assistant Administrator.
[FR Doc. 2022–17008 Filed 8–8–22; 8:45 am]
BILLING CODE P
jspears on DSK121TN23PROD with NOTICES
DEPARTMENT OF JUSTICE
ACTION:
Notice of application.
Bright Green Corporation has
applied to be registered as an importer
of basic class(es) of controlled
substance(s). Refer to SUPPLEMENTARY
INFORMATION listed below for further
drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before September 8, 2022. Such
persons may also file a written request
for a hearing on the application on or
before September 8, 2022.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment. All
requests for a hearing must be sent to:
(1) Drug Enforcement Administration,
Attn: Hearing Clerk/OALJ, 8701
Morrissette Drive, Springfield, Virginia
22152; and (2) Drug Enforcement
Administration, Attn: DEA Federal
Register Representative/DPW, 8701
Morrissette Drive, Springfield, Virginia
22152. All requests for a hearing should
also be sent to: Drug Enforcement
Administration, Attn: Administrator,
8701 Morrissette Drive, Springfield,
Virginia 22152.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.34(a), this
is notice that on July 11, 2022, Bright
Green Corporation, 1033 George Hanosh
Boulevard, Grants, New Mexico 87020,
applied to be registered as an importer
of the following basic class(es) of
controlled substance(s):
SUMMARY:
Controlled substance
Drug Enforcement Administration
[Docket No. DEA–1058]
Importer of Controlled Substances
Application: Bright Green Corporation
Drug Enforcement
Administration, Justice.
AGENCY:
VerDate Sep<11>2014
18:04 Aug 08, 2022
Jkt 256001
Marihuana Extract ...........
Marihuana ........................
Tetrahydrocannabinols ....
Drug
code
Schedule
7350
7360
7370
I
I
I
The company plans to import tissue
culture that will be used to begin the
propagation of their bulk cannabis
PO 00000
Frm 00062
Fmt 4703
Sfmt 4703
manufacturing operation. No other
activity for this drug code is authorized
for this registration.
Approval of permit applications will
occur only when the registrant’s
business activity is consistent with what
is authorized under 21 U.S.C. 952(a)(2).
Authorization will not extend to the
import of Food and Drug
Administration-approved or nonapproved finished dosage forms for
commercial sale.
Kristi O’Malley,
Assistant Administrator.
[FR Doc. 2022–16999 Filed 8–8–22; 8:45 am]
BILLING CODE P
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA–1063]
Bulk Manufacturer of Controlled
Substances Application: Chattem
Chemicals
Drug Enforcement
Administration, Justice.
ACTION: Notice of application.
AGENCY:
Chattem Chemicals has
applied to be registered as a bulk
manufacturer of basic class(es) of
controlled substance(s). Refer to
SUPPLEMENTARY INFORMATION listed
below for further drug information.
DATES: Registered bulk manufacturers of
the affected basic class(es), and
applicants therefore, may submit
electronic comments on or objections to
the issuance of the proposed registration
on or before October 11, 2022. Such
persons may also file a written request
for a hearing on the application on or
before October 11, 2022.
ADDRESSES: The Drug Enforcement
Administration requires that all
comments be submitted electronically
through the Federal eRulemaking Portal,
which provides the ability to type short
comments directly into the comment
field on the web page or attach a file for
lengthier comments. Please go to
https://www.regulations.gov and follow
the online instructions at that site for
submitting comments. Upon submission
of your comment, you will receive a
Comment Tracking Number. Please be
aware that submitted comments are not
instantaneously available for public
view on https://www.regulations.gov. If
you have received a Comment Tracking
Number, your comment has been
successfully submitted and there is no
need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In
accordance with 21 CFR 1301.33(a), this
SUMMARY:
E:\FR\FM\09AUN1.SGM
09AUN1
48513
Federal Register / Vol. 87, No. 152 / Tuesday, August 9, 2022 / Notices
is notice that on July 14, 2022, Chattem
Chemicals, 3801 Saint Elmo Avenue,
Chattanooga, Tennessee 37409–1237,
applied to be registered as a bulk
manufacturer of the following basic
class(es) of controlled substance(s):
Controlled substance
Drug code
Gamma Hydroxybutyric Acid .................................................................................................................................................
Marihuana ..............................................................................................................................................................................
Tetrahydrocannabinols ..........................................................................................................................................................
4-Methoxyamphetamine ........................................................................................................................................................
Noroxymorphone ...................................................................................................................................................................
Amphetamine .........................................................................................................................................................................
Methamphetamine .................................................................................................................................................................
Lisdexamfetamine ..................................................................................................................................................................
Methylphenidate ....................................................................................................................................................................
Cocaine ..................................................................................................................................................................................
Codeine .................................................................................................................................................................................
Dihydrocodeine ......................................................................................................................................................................
Oxycodone .............................................................................................................................................................................
Hydromorphone .....................................................................................................................................................................
Ecgonine ................................................................................................................................................................................
Hydrocodone .........................................................................................................................................................................
Levorphanol ...........................................................................................................................................................................
Methadone .............................................................................................................................................................................
Methadone intermediate ........................................................................................................................................................
Morphine ................................................................................................................................................................................
Oripavine ...............................................................................................................................................................................
Thebaine ................................................................................................................................................................................
Oxymorphone ........................................................................................................................................................................
Noroxymorphone ...................................................................................................................................................................
Alfentanil ................................................................................................................................................................................
Remifentanil ...........................................................................................................................................................................
Sufentanil ...............................................................................................................................................................................
Tapentadol .............................................................................................................................................................................
Fentanyl .................................................................................................................................................................................
The company plans to manufacture
the listed controlled substances in bulk
for distribution and sale to its
customers. In reference to drug codes
7360 (Marihuana) and 7370
(Tetrahydrocannabinols), the company
plans to bulk manufacture these drugs
as a synthetic. No other activities for
these drug codes are authorized for this
registration.
Kristi O’Malley,
Assistant Administrator.
Valorie Findlater, Office of Human
Capital, by email at valorie.findlater@
nara.gov or by telephone at (301) 837–
3754.
BILLING CODE P
NATIONAL ARCHIVES AND RECORDS
ADMINISTRATION
[NARA 2022–059]
Senior Executive Service (SES)
Performance Review Board; Members
Office of Human Capital,
National Archives and Records
Administration.
ACTION: Notice of membership on the
SES Performance Review Board.
jspears on DSK121TN23PROD with NOTICES
AGENCY:
Notice is hereby given of the
appointment of members of the National
Archives and Records Administration
(NARA) Performance Review Board
(PRB). The members of the PRB for the
SUMMARY:
18:04 Aug 08, 2022
Applicable Date: This
appointment is effective on August 9,
2022.
DATES:
FOR FURTHER INFORMATION CONTACT:
[FR Doc. 2022–17011 Filed 8–8–22; 8:45 am]
VerDate Sep<11>2014
National Archives and Records
Administration are: William J. Bosanko,
Chief Operating Officer; Micah M.
Cheatham, Chief of Management and
Administration; and Valorie F.
Findlater, Chief Human Capital Officer.
These appointments supersede all
previous appointments.
Jkt 256001
The
authority for this notice is 5 U.S.C.
4314(c), which also requires each
agency to establish, in accordance with
regulations prescribed by the Office of
Personnel Management, one or more
SES Performance Review Boards. The
Board shall review the initial appraisal
of a senior executive’s performance by
the supervisor and recommend final
action to the appointing authority
regarding matters related to senior
executive performance.
SUPPLEMENTARY INFORMATION:
Debra Steidel Wall,
Acting Archivist of the United States.
[FR Doc. 2022–17039 Filed 8–8–22; 8:45 am]
BILLING CODE 7515–01–P
PO 00000
Frm 00063
Fmt 4703
Sfmt 4703
2010
7360
7370
7411
9145
1100
1105
1205
1724
9041
9050
9120
9143
9150
9180
9193
9220
9250
9254
9300
9330
9333
9652
9668
9737
9739
9740
9780
9801
Schedule
I
I
I
I
I
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
II
NUCLEAR REGULATORY
COMMISSION
[NRC–2022–0148]
Monthly Notice; Applications and
Amendments to Facility Operating
Licenses and Combined Licenses
Involving No Significant Hazards
Considerations
Nuclear Regulatory
Commission.
ACTION: Monthly notice.
AGENCY:
Pursuant to section 189.a.(2)
of the Atomic Energy Act of 1954, as
amended (the Act), the U.S. Nuclear
Regulatory Commission (NRC) is
publishing this regular monthly notice.
The Act requires the Commission to
publish notice of any amendments
issued, or proposed to be issued, and
grants the Commission the authority to
issue and make immediately effective
any amendment to an operating license
or combined license, as applicable,
upon a determination by the
Commission that such amendment
involves no significant hazards
consideration (NSHC), notwithstanding
the pendency before the Commission of
a request for a hearing from any person.
DATES: Comments must be filed by
September 8, 2022. A request for a
hearing or petitions for leave to
SUMMARY:
E:\FR\FM\09AUN1.SGM
09AUN1
]]>Agencies
[Federal Register Volume 87, Number 152 (Tuesday, August 9, 2022)]
[Notices]
[Pages 48512-48513]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2022-17011]
-----------------------------------------------------------------------
DEPARTMENT OF JUSTICE
Drug Enforcement Administration
[Docket No. DEA-1063]
Bulk Manufacturer of Controlled Substances Application: Chattem
Chemicals
AGENCY: Drug Enforcement Administration, Justice.
ACTION: Notice of application.
-----------------------------------------------------------------------
SUMMARY: Chattem Chemicals has applied to be registered as a bulk
manufacturer of basic class(es) of controlled substance(s). Refer to
SUPPLEMENTARY INFORMATION listed below for further drug information.
DATES: Registered bulk manufacturers of the affected basic class(es),
and applicants therefore, may submit electronic comments on or
objections to the issuance of the proposed registration on or before
October 11, 2022. Such persons may also file a written request for a
hearing on the application on or before October 11, 2022.
ADDRESSES: The Drug Enforcement Administration requires that all
comments be submitted electronically through the Federal eRulemaking
Portal, which provides the ability to type short comments directly into
the comment field on the web page or attach a file for lengthier
comments. Please go to https://www.regulations.gov and follow the
online instructions at that site for submitting comments. Upon
submission of your comment, you will receive a Comment Tracking Number.
Please be aware that submitted comments are not instantaneously
available for public view on https://www.regulations.gov. If you have
received a Comment Tracking Number, your comment has been successfully
submitted and there is no need to resubmit the same comment.
SUPPLEMENTARY INFORMATION: In accordance with 21 CFR 1301.33(a), this
[[Page 48513]]
is notice that on July 14, 2022, Chattem Chemicals, 3801 Saint Elmo
Avenue, Chattanooga, Tennessee 37409-1237, applied to be registered as
a bulk manufacturer of the following basic class(es) of controlled
substance(s):
------------------------------------------------------------------------
Controlled substance Drug code Schedule
------------------------------------------------------------------------
Gamma Hydroxybutyric Acid.................. 2010 I
Marihuana.................................. 7360 I
Tetrahydrocannabinols...................... 7370 I
4-Methoxyamphetamine....................... 7411 I
Noroxymorphone............................. 9145 I
Amphetamine................................ 1100 II
Methamphetamine............................ 1105 II
Lisdexamfetamine........................... 1205 II
Methylphenidate............................ 1724 II
Cocaine.................................... 9041 II
Codeine.................................... 9050 II
Dihydrocodeine............................. 9120 II
Oxycodone.................................. 9143 II
Hydromorphone.............................. 9150 II
Ecgonine................................... 9180 II
Hydrocodone................................ 9193 II
Levorphanol................................ 9220 II
Methadone.................................. 9250 II
Methadone intermediate..................... 9254 II
Morphine................................... 9300 II
Oripavine.................................. 9330 II
Thebaine................................... 9333 II
Oxymorphone................................ 9652 II
Noroxymorphone............................. 9668 II
Alfentanil................................. 9737 II
Remifentanil............................... 9739 II
Sufentanil................................. 9740 II
Tapentadol................................. 9780 II
Fentanyl................................... 9801 II
------------------------------------------------------------------------
The company plans to manufacture the listed controlled substances
in bulk for distribution and sale to its customers. In reference to
drug codes 7360 (Marihuana) and 7370 (Tetrahydrocannabinols), the
company plans to bulk manufacture these drugs as a synthetic. No other
activities for these drug codes are authorized for this registration.
Kristi O'Malley,
Assistant Administrator.
[FR Doc. 2022-17011 Filed 8-8-22; 8:45 am]
BILLING CODE P
